Testing Positive for Covid-19, Signs and Symptoms, Treatment, and Covid-19-Related Anxiety: A Case of Factory Workers

Year 2024, Volume: 14 Issue: 1, 1 - 7, 28.03.2024

Serap Batı , Rukiye Burucu

https://doi.org/10.33808/clinexphealthsci.996248

Abstract

Objective: This paper investigated the incidence of COVID-19 contraction, signs and symptoms, treatment, pandemic-related anxiety, and related factors in factory workers.
Methods: This was a descriptive study conducted in a factory operating in the textile industry. No sampling was performed. The sample consisted of 287 volunteers. Data were collected using a sociodemographic characteristics questionnaire and the Coronavirus Anxiety Scale Short Form.
Results: Less than half the participants tested positive for COVID-19 (41.1%). They were treated at home (68.6%) or in a hospital (19.5%). The most common symptoms were fatigue, joint pain, change in the sense of taste, and headache. The mean duration of home and hospital treatment was 7.00±0.00 and 12.49±6.14, respectively. Participants had a mean anxiety scale score of 7.65±3.71. Less than half the
participants (31%) had high COVID-19 anxiety levels. The incidence of COVID-19 infection and anxiety was higher in participants who were on medication for chronic illnesses. Age and BMI were correlated with hospitalization for COVID-19.
Conclusions: The incidence of COVID-19 infection is high among factory workers. Therefore, authorities should consider them a priority group for vaccination and provide them with training on COVID-19 risk factors and preventive measures.

Keywords

COVID-19, anxiety, risk factor, chronic illness

References

• Yürük Bal E, Çelik H. COVID-19 the role of nursing in the struggle against outbreaks. Turkiye Klinikleri Journal of Nursing Sciences. 2020;12(2): 300-304 DOI: 10.5336/nurses.2020-75315
• Ong SWX, Tan YK, Chia PY. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (sars-cov-2) from a symptomatic patient. JAMA 2020;323(16):1610-1612. DOI:10.1001/jama.2020.3227
• Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020;10(40):1-5 DOI:10.1186/s13578-020-00404-4
• World Health Organization.Coronavirus disease (COVID-19) pandemic. Published [22 March 2020]. Updated [27 May 2021]. Accessed [20 July 2021]. https://www.who.int/europe/emergencies/situations/covid-19
• Taşkaldıran I, Bayraktaroğlu T. The C COVID-19 ve hipertansiyon. Türk Diyabet ve Obezite Dergisi. 2020;4(2):155-159. DOI:10.25048/tudod.752989 (Turkish)
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. DOI:10.1056/NEJMoa2002032
• Khateri S, Mohammadi H, Khateri R, Moradi Y. The prevalence of underlying diseases and comorbidities in Covıd-19 patients; an updated systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e72.
• Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with covıd-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.
• Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of ınfection associated with the 2019 novel coronavirus ındicating possible person-to-person transmission during the ıncubation period. The Journal of Infectious Diseases. 2020;221(11):1757-1761. DOI:10.1093/infdis/jiaa077
• Kimball A, Hatfield KM, Arons M. Asymptomatic and presymptomatic SARS-CoV-2 ınfections in residents of a long-term care skilled nursing facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):377-381. DOI:10.15585/mmwr.mm6913e1
• Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020;66(4):317-320. DOI:10.1177/0020764020915212
• Rubin GJ, Wessely S. The psychological effects of quarantining a city. BMJ. 2020;368:m313. DOI:10.1136/bmj.m313
• Taylan S, Alan S, Kadıoğlu S. Roles of Nursing and Autonomy. HEMAR-G. 2012;3:66-74 (Turkish)
• Yıldırım Kaptanoğlu A. Sağlık Alanında Hipotezden Teze. Beşir Kitabevi İstanbul. 2013 (Turkish)
• Gürbüz M, Tevfikoğlu Pehlivan L. Obezite, COVID-19 pandemisinde risk faktörü müdür? Turkiye Klinikleri Sağlık Bilimleri Dergisi 2020;5(2):313-22. DOI: 10.5336/healthsci.2020-75675 (Turkish)
• Martin ET, Archer C, McRoberts J, et al. Epidemiology of severe influenza outcomes among adult patients with obesity in Detroit, Michigan, 2011. Influenza Other Respir Viruses 2013;7(6):1004-1007. DOI:10.1111/irv.12115
• Menni C, Sudre CH, Steves CJ, Ourselin S, Spector TD. Quantifying additional COVID-19 symptoms will save lives. Lancet. 2020;395(10241):e107-e108. DOI:10.1016/S0140-6736(20)31281-2
• Menni C, Klaser K, May A. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study. Lancet Infect Dis. 2021;21(7):939-949. DOI:10.1016/S1473-3099(21)00224-3
• Biçer İ, Çakmak C, Demir HC. Koronavirüs anksiyete ölçeği kısa formu: türkçe geçerlik ve güvenirlik çalışması. A Anadolu Kliniği Tıp Bilimleri Dergisi 2020:216-25. DOI: 10.21673/anadoluklin.731092 (Turkish)
• Karaçam Z. STROBE gözlemsel araştırmalarda yazım standardizasyonu. Ankara Nobel Tıp Kitabevi 2018; Ankara (Turkish)
• World Health Organization. WHO COVID-19 dashboard. https://data.who.int/dashboards/covid19/data
• Kara E. COVID-19 pandemisi: işgücü üzerindeki etkileri ve istihdam tedbirleri. E Avrasya Sosyal ve Ekonomi Araştırmaları Dergisi 2020;7(5):299-82 (Turkish)
• Menni C, Valdes AM, Freidin MB. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037-1040. DOI:10.1038/s41591-020-0916-2
• Lan FY, Filler R, Mathew S. COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results. PLoS One. 2020;15(6):e0235460. DOI:10.1371/journal.pone.0235460
• Toptan T, Aktan Ç, Başarı A, Bolay H. Case series of headache characteristics in COVID-19: headache can be an ısolated symptom. Headache. 2020;60(8):1788-1792. DOI:10.1111/head.13940
• Lippi G, Mattiuzzi C, Bovo C, Henry BM. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19). Diagnosis (Berl). 2020;7(4):409-411. DOI:10.1515/dx-2020-0048
• Townsend L, Dyer AH, Jones K. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. DOI:10.1371/journal.pone.0240784
• Honce R, Schultz-Cherry S. Impact of obesity on influenza a virus pathogenesis, immune response, and evolution. Front Immunol. 2019;10:1071. DOI:10.3389/fimmu.2019.01071
• Huang R, Zhu L, Xue L. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study. PLoS Negl Trop Dis. 2020;14(5):e0008280. DOI:10.1371/journal.pntd.0008280
• Yu S, Xing L, Du Z, Prevalence of obesity and associated risk factors and cardiometabolic comorbidities in rural Northeast China. Biomed Res Int. 2019;2019:6509083. DOI:10.1155/2019/6509083
• Moghanibashi-Mansourieh A. Assessing the anxiety level of Iranian general population during COVID-19 outbreak. Asian J Psychiatr. 2020;51:102076. DOI:10.1016/j.ajp.2020.102076
• Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry. 2020;66(5):504-511. DOI:10.1177/0020764020927051
• Shangguan F, Quan X, Qian W, Prevalence and correlates of somatization in anxious individuals in a Chinese online crisis intervention during COVID-19 epidemic. J Affect Disord. 2020;277:436-442. DOI:10.1016/j.jad.2020.08.035
• Petzold MB, Bendau A, Plag J. Risk, resilience, psychological distress, and anxiety at the beginning of the COVID-19 pandemic in Germany. Brain Behav. 2020;10(9):e01745. DOI:10.1002/brb3.1745